Page last updated: 2024-08-21

pyrazines and Dermatitis Medicamentosa

pyrazines has been researched along with Dermatitis Medicamentosa in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (9.38)	18.7374
1990's	0 (0.00)	18.2507
2000's	15 (46.88)	29.6817
2010's	11 (34.38)	24.3611
2020's	3 (9.38)	2.80

Authors

Authors	Studies
Punyaratabandhu, P; Vanitchpongphan, S	1
Bhattacharyya, A; Kim, J; Truong, K; Wells, J	1
Beylot-Barry, M; Protin, C; Recher, C; Sibaud, V; Vigarios, E; Ysebaert, L	1
Goebeler, M; Kneitz, H; Kolb-Mäurer, A	1
Özkaya, E	1
Katoh, N; Nakai, N	1
Kim, DW; Kim, M; Lee, JH; Park, HJ; Yoon, YH	1
García-Bustínduy, M; Martín-Herrera, A; Noda-Cabrera, A; Rodríguez-Martín, M; Sáez-Rodríguez, M	1
Barr, RJ; Cole, GW; Dyson, SW; Murase, JE; Theate, I; Wu, JJ	1
Aki, SZ; Erdem, O; Ozkurt, ZN; Sucak, GT; Yağci, M	1
Bölke, E; Bruch-Gerharz, D; Budach, W; Buhren, BA; Fenk, R; Gerber, PA; Haas, R; Homey, B; Reifenberger, J	1
Mehta, AB; Shah, AD; Watts, AJ; Wechalekar, AD	1
Bastida, J; Campos-Adsuar, C; Dehesa, L; Gómez-Duaso, J; Limeres-González, M	1
Appenzeller, M; Bigliardi, P; Buclin, T; Grouzmann, E; Pannatier, A	1
Ogawa, Y; Shimada, S; Tanaka, K	1
Caminal-Montero, L; Coto-Segura, P; Esteve-Martinez, A; Mas-Vidal, A; Santos-Juanes, J	1
Ferrara, R; Obeid, KM; Sharma, M	1
Alcántara, J; Bagazgoitia, L; Carrillo, R; Truchuelo, M; Velasco, D	1
Auberger, J; Clausen, J; Greil, R; Hopfinger, G; Vogt, S	1
Agterof, MJ; Biesma, DH	1
Ferrant, A; Jacquemain, A; Knoops, L; Tennstedt, D; Theate, I; Van den Neste, E	1
Hajek, R; Krejci, M; Krivanova, A; Pour, L; Vorlicek, J; Zdenek, A	1
Alacacioglu, I; Ceneli, S; Demirkan, F; Lebe, B; Ozcan, MA; Ozsan, GH; Piskin, O; Turgut, N; Undar, B	1
Heule, F; Lam, K; Sonneveld, P; Wu, KL	1
Betlloch, I; Botella, C; Lucas, A; Mataix, J; Villarrubia, B	1
Alomar, A; Dalmau, J; Fernández-Figueras, MT; Garcia-Navarro, X; Puig, L; Roe, E	1
Kurtis, B; Lacouture, ME; Mekki, M; Newman, MA; Paiva, CM; Singhal, S	1
Dietrich, PY; Favet, L; Kerl, K; Piguet, V; Sanchez-Politta, S	1
Betlloch, I; Mataix, J; Palmero, F; Romero, A	1
Gates, T; Maibach, H; Okun, R	1
Nash, DT	1
Caputo, G; Emanueli, A; Molari, E; Pirola, LC	1

Reviews

5 review(s) available for pyrazines and Dermatitis Medicamentosa

Article	Year
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors. American journal of clinical dermatology, 2020, Volume: 21, Issue:6 Topics: Adenine; Administration, Cutaneous; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Biopsy; Drug Eruptions; Ecchymosis; Emollients; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Necrosis; Patient Education as Topic; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Antigen, B-Cell; Severity of Illness Index; Signal Transduction; Skin; Skin Care	2020
Maculopapular-type drug eruption caused by sitagliptin phosphate hydrate: a case report and mini-review of the published work. Allergology international : official journal of the Japanese Society of Allergology, 2014, Volume: 63, Issue:3 Topics: Aged; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Drug Eruptions; Female; Humans; Hypersensitivity, Delayed; Hypoglycemic Agents; Immunologic Tests; Lymphocyte Activation; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Skin; Triazoles; Withholding Treatment	2014
Eruptive Melanocytic Naevi Caused by Radotinib Therapy in Patients with Chronic Myeloid Leukaemia: 10 cases and a literature Review. Acta dermato-venereologica, 2017, 01-04, Volume: 97, Issue:1 Topics: Adult; Aged; Benzamides; Drug Eruptions; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nevus, Pigmented; Pyrazines	2017
Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:9 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Male; Middle Aged; Pyrazines; Sweet Syndrome	2012
Bortezomib-associated cutaneous vasculitis. The British journal of dermatology, 2007, Volume: 157, Issue:4 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Female; Humans; Male; Middle Aged; Protease Inhibitors; Pyrazines; Skin Diseases, Vascular; Vasculitis	2007

Trials

3 trial(s) available for pyrazines and Dermatitis Medicamentosa

Article	Year
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers. Biological chemistry, 2011, Volume: 392, Issue:3 Topics: Capsaicin; Carbonated Beverages; Cross-Over Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Edema; Erythema; Humans; Injections, Intradermal; Male; Pain; Pyrazines; Sitagliptin Phosphate; Skin; Substance P; Triazoles; Vasodilation	2011
Acute acneiform eruption secondary to MK-672. Archives of dermatology, 1971, Volume: 104, Issue:5 Topics: Acne Vulgaris; Animals; Antihypertensive Agents; Biopsy; Clinical Trials as Topic; Corynebacterium; Drug Eruptions; Humans; Imidazoles; Placebos; Pyrazines; Skin	1971
Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases. Arzneimittel-Forschung, 1972, Volume: 22, Issue:11 Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Blood Glucose; Blood Proteins; Cholesterol; Clinical Trials as Topic; Cyclohexanes; Diabetes Mellitus; Drug Eruptions; Female; Glycosuria; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Nausea; Prothrombin Time; Pyrazines; Sulfonylurea Compounds; Tolbutamide; Transaminases; Vomiting	1972

Other Studies

24 other study(ies) available for pyrazines and Dermatitis Medicamentosa

Article	Year
Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19. Clinical and experimental dermatology, 2022, Volume: 47, Issue:3 Topics: Adult; Amides; Antiviral Agents; COVID-19 Drug Treatment; Drug Eruptions; Female; Humans; Middle Aged; Pyrazines; Urticaria; Young Adult	2022
A uniquely distributed purpuric drug eruption from acalabrutinib. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Drug Eruptions; Humans; Piperidines; Protein Kinase Inhibitors; Purpura; Pyrazines; Quality of Life	2022
Sweet-like syndrome induced by bortezomib. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2013, Volume: 11, Issue:12 Topics: Adrenal Cortex Hormones; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Male; Multiple Myeloma; Pyrazines; Sweet Syndrome; Treatment Outcome	2013
Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results. Cutis, 2013, Volume: 92, Issue:3 Topics: Antitubercular Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Ethambutol; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Patch Tests; Pyrazines; Rifampin	2013
Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report. Dermatology online journal, 2008, Nov-15, Volume: 14, Issue:11 Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Eruptions; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Multiple Myeloma; Prednisone; Protease Inhibitors; Pyrazines; Salvage Therapy; Vincristine	2008
Bortezomib-induced histiocytoid Sweet syndrome. Journal of the American Academy of Dermatology, 2009, Volume: 60, Issue:3 Topics: Aged; Biopsy; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Male; Multiple Myeloma; Protease Inhibitors; Pyrazines; Sweet Syndrome	2009
Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma. Cutaneous and ocular toxicology, 2009, Volume: 28, Issue:3 Topics: Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Drug Eruptions; Exanthema; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome	2009
Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases. Wiener klinische Wochenschrift, 2009, Volume: 121, Issue:21-22 Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Erythema Multiforme; Humans; Male; Middle Aged; Pyrazines	2009
An unusual case of transient dermatological reaction to bortezomib in AL amyloidosis. International journal of hematology, 2010, Volume: 91, Issue:1 Topics: Amyloidosis; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Paraproteinemias; Protease Inhibitors; Pyrazines	2010
Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib. Clinical and experimental dermatology, 2009, Volume: 34, Issue:8 Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Ki-1 Antigen; Male; Multiple Myeloma; Pyrazines; T-Lymphocyte Subsets	2009
Drug eruption caused by sitagliptin, a dipeptidyl peptidase-IV inhibitor. The Journal of dermatology, 2012, Volume: 39, Issue:8 Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Middle Aged; Pruritus; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Triazoles	2012
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor. The Australasian journal of dermatology, 2012, Volume: 53, Issue:1 Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Extremities; Female; Humans; Middle Aged; Psoriasis; Pyrazines; Sitagliptin Phosphate; Torso; Triazoles	2012
Cutaneous lesion induced by a subcutaneous administration of bortezomib. Clinical lymphoma, myeloma & leukemia, 2012, Volume: 12, Issue:4 Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Infusions, Subcutaneous; Male; Multiple Myeloma; Pyrazines	2012
Topical evening primrose oil for reduction of bortezomib-induced skin reactions. Annals of hematology, 2013, Volume: 92, Issue:7 Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Boronic Acids; Bortezomib; Drug Eruptions; Drug Evaluation; gamma-Linolenic Acid; Humans; Injections, Subcutaneous; Linoleic Acids; Oenothera biennis; Phytotherapy; Plant Oils; Protease Inhibitors; Pyrazines	2013
Images in clinical Medicine. Bortezomib-induced skin lesions. The New England journal of medicine, 2005, Jun-16, Volume: 352, Issue:24 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Female; Humans; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines	2005
Bortezomib-induced Sweet syndrome. British journal of haematology, 2005, Volume: 131, Issue:2 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Pyrazines; Sweet Syndrome	2005
Skin lesions induced by bortezomib. Haematologica, 2005, Volume: 90, Issue:12 Suppl Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cetirizine; Combined Modality Therapy; Dexamethasone; Drug Eruptions; Exanthema; Histamine H1 Antagonists, Non-Sedating; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Prednisone; Pyrazines; Salvage Therapy	2005
Bortezomib-induced skin lesion. Acta haematologica, 2006, Volume: 116, Issue:3 Topics: Aged, 80 and over; Boronic Acids; Bortezomib; Drug Eruptions; Female; Humans; Multiple Myeloma; Pyrazines	2006
Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Topics: Adult; Aged; Boronic Acids; Bortezomib; Drug Eruptions; Drug Therapy, Combination; Erythema; Fever; Glucocorticoids; Histamine H1 Antagonists; Humans; Male; Medical Records; Middle Aged; Multiple Myeloma; Prednisone; Protease Inhibitors; Pyrazines; Skin; Skin Ulcer	2006
Bortezomib-associated rash: a new recognizable and avoidable side-effect. The British journal of dermatology, 2007, Volume: 156, Issue:4 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Exanthema; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines	2007
Neutrophilic dermatitis associated with bortezomib in a patient with multiple myeloma. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:10 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Male; Middle Aged; Multiple Myeloma; Neutrophil Infiltration; Pyrazines	2007
Bortezomib-induced skin eruption. Dermatology (Basel, Switzerland), 2008, Volume: 216, Issue:2 Topics: Antineoplastic Agents; Biopsy; Boronic Acids; Bortezomib; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Skin	2008
Persistent supravenous eruption induced by intravenous bortezomib therapy. The British journal of dermatology, 2008, Volume: 158, Issue:4 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Eruptions; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrazines; Vascular Diseases; Veins	2008
A clinical study of Co-hydroDiuril a combination of an antikaliuretic (amiloride) and hydrochlorothiazide. Current therapeutic research, clinical and experimental, 1972, Volume: 14, Issue:9 Topics: Adult; Aged; Amiloride; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Combinations; Drug Eruptions; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Pyrazines; Urinary Incontinence; Vertigo	1972